SsangYong Motor Co. is to begin a court-led restructuring process as early as next week after sole potential investor HAAH Automotive Holdings Inc failed to submit a letter of intent by March 31 to acquire it.
The Seoul Bankruptcy Court ordered SsangYong to submit HAAH's letter of intent.
Mahindra & Mahindra Ltd., SsangYong Motor's Indian parent, has been in talks with US vehicle importer HAAH to sell its majority stake in the Korean unit.
The talks were held as SsangYong filed for court receivership in December after failing to obtain approval for the rollover of 165 billion won worth of loans from creditors.
SsangYong was given a three-month suspension of its obligation to pay the debts due to the talks with HAAH.
Main creditor Korea Development Bank said it hasn't received any notice or documents from the court.
SsangYong was planning to submit its plan for a speedier rehabilitation procedure under a "prepackaged" bankruptcy plan if HAAH had submitted the letter of intent.
The prepackaged plan is a combination of workout and court protection under which a restructuring plan is agreed upon in advance of a company declaring its insolvency. It is intended to shorten and streamline the bankruptcy process.


NAB Q3 Cash Earnings Rise 2% as Lower Credit Charges Boost Profit
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
OpenAI Tightens AI Safety Monitoring After Security Incidents
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Nvidia’s $500 Billion AI Infrastructure Push Wins Morgan Stanley Support
Alphabet Shifts AI Strategy Toward Commercial Growth, Goldman Sachs Says
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Synlait Milk Denies Fonterra, a2 Milk Takeover Talks
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme 



